| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | Dec 4, 2025 | STANDARD BIOTOOLS INC. | Director | Buy | 67.5 | +350,000 | 0.47% | ✗ | $502.6K |
| Nov 24, 2025 | Nov 26, 2025 | STANDARD BIOTOOLS INC. | Director | Buy | 100.0 | +7,700,000 | 11.50% | ✗ | $10.1M |
| Nov 18, 2025 | Nov 20, 2025 | STANDARD BIOTOOLS INC. | Director | Buy | 87.5 | +1,075,000 | 1.63% | ✗ | $1.4M |
| Nov 13, 2025 | Nov 17, 2025 | STANDARD BIOTOOLS INC. | Director | Buy | 87.5 | +925,000 | 1.37% | ✗ | $1.1M |
| Nov 7, 2025 | Nov 12, 2025 | STANDARD BIOTOOLS INC. | Director | Buy | 87.5 | +1,175,000 | 1.84% | ✗ | $1.4M |
| Oct 15, 2025 | Oct 17, 2025 | BIOLIFE SOLUTIONS INC | 10% Owner | Sell | 15.0 | -750,000 | -11.18% | ✗ | $21.4M |
| Sep 9, 2025 | Sep 11, 2025 | STANDARD BIOTOOLS INC. | Director | Buy | 60.0 | +100,000 | 0.16% | ✗ | $128.9K |
| Sep 3, 2025 | Sep 5, 2025 | STANDARD BIOTOOLS INC. | Director | Buy | 75.0 | +500,000 | 0.79% | ✗ | $635.8K |
| Aug 22, 2025 | Aug 26, 2025 | STANDARD BIOTOOLS INC. | Director | Buy | 75.0 | +525,000 | 0.84% | ✗ | $658.8K |
| Aug 22, 2025 | Aug 22, 2025 | GeneDx Holdings Corp. | Director | Sell | 15.0 | -500,000 | -14.17% | ✗ | $60.5M |
| Aug 15, 2025 | Aug 21, 2025 | BIOLIFE SOLUTIONS INC | 10% Owner | Sell | 15.0 | -500,000 | -6.94% | ✗ | $12.2M |
| Aug 13, 2025 | Aug 15, 2025 | STANDARD BIOTOOLS INC. | Director | Buy | 75.0 | +358,220 | 0.58% | ✗ | $443K |
| Aug 11, 2025 | Aug 13, 2025 | BIOLIFE SOLUTIONS INC | 10% Owner | Sell | 15.0 | -500,000 | -6.49% | ✗ | $11.3M |
| Jun 10, 2025 | Jun 12, 2025 | BIOLIFE SOLUTIONS INC | 10% Owner | Sell | 15.0 | -1,000,000 | -11.48% | ✗ | $23.8M |
| Feb 28, 2025 | Mar 4, 2025 | STANDARD BIOTOOLS INC. | Director | Buy | 93.8 | +4,879,174 | 4.20% | ✗ | $5.1M |
| Aug 27, 2024 | Aug 29, 2024 | STANDARD BIOTOOLS INC. | Director | Buy | 67.5 | +250,000 | 0.44% | ✗ | $546.8K |
| Aug 22, 2024 | Aug 26, 2024 | STANDARD BIOTOOLS INC. | Director | Buy | 77.5 | +750,000 | 0.69% | ✗ | $1.5M |
| Aug 19, 2024 | Aug 21, 2024 | STANDARD BIOTOOLS INC. | Director | Buy | 87.5 | +1,250,000 | 2.29% | ✗ | $2.4M |
| Aug 14, 2024 | Aug 16, 2024 | STANDARD BIOTOOLS INC. | Director | Buy | 87.5 | +1,200,000 | 2.25% | ✗ | $1.9M |
| Aug 9, 2024 | Aug 13, 2024 | STANDARD BIOTOOLS INC. | Director | Buy | 92.5 | +1,575,408 | 3.04% | ✗ | $2.6M |
| Aug 7, 2024 | Aug 9, 2024 | STANDARD BIOTOOLS INC. | Director | Buy | 87.5 | +1,069,562 | 1.08% | ✗ | $1.7M |
| Aug 2, 2024 | Aug 6, 2024 | STANDARD BIOTOOLS INC. | Director | Buy | 87.5 | +1,200,000 | 1.89% | ✗ | $1.9M |
| Aug 1, 2024 | Aug 5, 2024 | GeneDx Holdings Corp. | Director | Buy | 100.0 | +413,655 | 12.00% | ✗ | $13.3M |
| Jun 3, 2024 | Jun 5, 2024 | GeneDx Holdings Corp. | Director | Buy | 92.5 | +130,000 | 3.49% | ✗ | $2.8M |
| May 29, 2024 | May 31, 2024 | GeneDx Holdings Corp. | Director | Buy | 85.0 | +40,000 | 1.08% | ✗ | $842.6K |
| May 23, 2024 | May 28, 2024 | STANDARD BIOTOOLS INC. | Director | Buy | 67.5 | +100,000 | 0.22% | ✗ | $260K |
| May 23, 2024 | May 28, 2024 | GeneDx Holdings Corp. | Director | Buy | 92.5 | +170,000 | 4.83% | ✗ | $3.4M |
| May 20, 2024 | May 22, 2024 | STANDARD BIOTOOLS INC. | Director | Buy | 87.5 | +600,000 | 1.32% | ✗ | $1.5M |
| May 15, 2024 | May 17, 2024 | STANDARD BIOTOOLS INC. | Director | Buy | 92.5 | +1,352,072 | 3.06% | ✗ | $3.5M |
| May 13, 2024 | May 15, 2024 | GeneDx Holdings Corp. | Director | Buy | 87.5 | +50,000 | 1.44% | ✗ | $1.2M |
| Mar 4, 2024 | Mar 6, 2024 | GeneDx Holdings Corp. | Director | Buy | 85.0 | +40,900 | 1.19% | ✗ | $357.7K |
| Mar 4, 2024 | Mar 6, 2024 | STANDARD BIOTOOLS INC. | Director | Buy | 85.0 | +251,403 | 1.11% | ✗ | $646.2K |
| Oct 19, 2023 | Oct 23, 2023 | BIOLIFE SOLUTIONS INC | 10% Owner | Buy | 100.0 | +927,165 | 11.92% | ✗ | $10.4M |
| Aug 9, 2023 | Aug 11, 2023 | BIOLIFE SOLUTIONS INC | 10% Owner | Buy | 75.0 | +58,465 | 0.76% | ✗ | $771.7K |
| May 19, 2023 | May 23, 2023 | BIOLIFE SOLUTIONS INC | 10% Owner | Buy | 77.5 | +74,973 | 0.98% | ✗ | $1.7M |
| May 17, 2023 | May 19, 2023 | STANDARD BIOTOOLS INC. | Director | Buy | 100.0 | +1,200,000 | 100.00% | ✗ | $2.6M |
| May 16, 2023 | May 18, 2023 | BIOLIFE SOLUTIONS INC | 10% Owner | Buy | 77.5 | +75,027 | 0.99% | ✗ | $1.6M |
| Oct 3, 2022 | Oct 5, 2022 | MAXCYTE, INC. | 10% Owner | Sell | 17.5 | -735,786 | -6.85% | ✗ | $4.5M |
| Jul 1, 2022 | Jul 6, 2022 | MAXCYTE, INC. | 10% Owner | Sell | 15.0 | -3,235,548 | -23.16% | ✗ | $13.9M |
| Jul 30, 2021 | Aug 3, 2021 | MAXCYTE, INC. | 10% Owner | Buy | 100.0 | +1,800,000 | 14.79% | ✗ | $23.4M |
| Jul 26, 2021 | Jul 28, 2021 | Absci Corp | Director | Buy | 100.0 | +1,562,500 | 30.15% | ✗ | $25M |
| Nov 24, 2020 | Nov 27, 2020 | BIOLIFE SOLUTIONS INC | 10% Owner | Buy | 100.0 | +1,600,000 | 27.40% | ✗ | $36M |
| Jul 1, 2020 | Jul 2, 2020 | BIOLIFE SOLUTIONS INC | 10% Owner | Buy | 100.0 | +990,583 | 20.43% | ✗ | $14.4M |
| May 22, 2020 | May 26, 2020 | BIOLIFE SOLUTIONS INC | 10% Owner | Buy | 100.0 | +476,191 | 10.89% | ✗ | $5M |
| May 14, 2020 | May 18, 2020 | BIOLIFE SOLUTIONS INC | 10% Owner | Buy | 100.0 | +1,904,762 | 77.16% | ✗ | $20M |
| Nov 19, 2019 | Nov 21, 2019 | BIOLIFE SOLUTIONS INC | 10% Owner | Buy | 85.0 | +40,000 | 1.65% | ✗ | $616.5K |
| Jul 22, 2019 | Jul 22, 2019 | Fulcrum Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +140,000 | 30.15% | ✗ | $2.2M |